ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pulmotect's Positive Topline Results for Inhaled PUL-042 against COVID-19 Delivered by PARI Nebulizer
October 13, 2021Pulmotect reported positive topline results from their randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19. Patients treated with inhaled PUL-042 had a statistically significant reduction... -
PARI Devices Used in SHIP Study of Hypertonic Saline in Preschoolers with Cystic Fibrosis
November 30, 2018A recent study in preschoolers with cystic fibrosis (CF) conducted by Cystic Fibrosis Foundation Therapeutics used PARI's LC Sprint Jr. nebulizer, Vios PRO compressor.....
Pharma Sources Insight January 2025
